| Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC A Caraceni, G Hanks, S Kaasa, MI Bennett, C Brunelli, N Cherny, O Dale, ... The lancet oncology 13 (2), e58-e68, 2012 | 1581 | 2012 |
| The 118 A> G polymorphism in the human µ‐opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease P Klepstad, TT Rakvåg, S Kaasa, M Holthe, O Dale, PC Borchgrevink, ... Acta Anaesthesiologica Scandinavica 48 (10), 1232-1239, 2004 | 471 | 2004 |
| The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients TT Rakvåg, P Klepstad, C Baar, TM Kvam, O Dale, S Kaasa, HE Krokan, ... Pain 116 (1-2), 73-78, 2005 | 413 | 2005 |
| Health care providers underestimate symptom intensities of cancer patients: a multicenter European study EA Laugsand, MAG Sprangers, K Bjordal, F Skorpen, S Kaasa, ... Health and quality of life outcomes 8, 1-13, 2010 | 397 | 2010 |
| Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene CC Reyes-Gibby, S Shete, T Rakvåg, SV Bhat, F Skorpen, E Bruera, ... Pain 130 (1-2), 25-30, 2007 | 377 | 2007 |
| The Norwegian brief pain inventory questionnaire: translation and validation in cancer pain patients P Klepstad, JH Loge, PC Borchgrevink, TR Mendoza, CS Cleeland, ... Journal of pain and symptom management 24 (5), 517-525, 2002 | 375 | 2002 |
| Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients P Klepstad, T Fladvad, F Skorpen, K Bjordal, A Caraceni, O Dale, ... Pain 152 (5), 1139-1145, 2011 | 233 | 2011 |
| Efficacy of methylprednisolone on pain, fatigue, and appetite loss in patients with advanced cancer using opioids: a randomized, placebo-controlled, double-blind trial Ø Paulsen, P Klepstad, JH Rosland, N Aass, E Albert, P Fayers, S Kaasa Journal of Clinical Oncology 32 (29), 3221-3228, 2014 | 213 | 2014 |
| Prognostic factors in patients with advanced cancer: a comparison of clinicopathological factors and the development of an inflammation-based prognostic system BJ Laird, S Kaasa, DC McMillan, MT Fallon, MJ Hjermstad, P Fayers, ... Clinical Cancer Research 19 (19), 5456-5464, 2013 | 205 | 2013 |
| Evidence of a role for NMDA receptors in pain perception P Klepstad, A Maurset, ER Moberg, I Øye European journal of pharmacology 187 (3), 513-518, 1990 | 200 | 1990 |
| Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to … M Holthe, TN Rakvåg, P Klepstad, JR Idle, S Kaasa, HE Krokan, ... The pharmacogenomics journal 3 (1), 17-26, 2003 | 194 | 2003 |
| Pain and pain treatments in European palliative care units. A cross sectional survey from the European Association for Palliative Care Research Network P Klepstad, S Kaasa, N Cherny, G Hanks, F De Conno, ... Palliative medicine 19 (6), 477-484, 2005 | 187 | 2005 |
| Genetic Variation in the Catechol-O-Methyltransferase (COMT) Gene and Morphine Requirements in Cancer Patients with Pain TT Rakvåg, JR Ross, H Sato, F Skorpen, S Kaasa, P Klepstad Molecular pain 4, 1744-8069-4-64, 2008 | 185 | 2008 |
| Quality of life in patients with advanced cancer: differential association with performance status and systemic inflammatory response BJA Laird, M Fallon, MJ Hjermstad, S Tuck, S Kaasa, P Klepstad, ... Journal of Clinical Oncology 34 (23), 2769-2775, 2016 | 169 | 2016 |
| Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine … M Holthe, P Klepstad, K Zahlsen, PC Borchgrevink, L Hagen, O Dale, ... European journal of clinical pharmacology 58, 353-356, 2002 | 169 | 2002 |
| The systemic inflammatory response and its relationship to pain and other symptoms in advanced cancer BJ Laird, DC McMillan, P Fayers, K Fearon, S Kaasa, MT Fallon, ... The oncologist 18 (9), 1050-1055, 2013 | 164 | 2013 |
| Severe head injury: control of physiological variables, organ failure and complications in the intensive care unit K Schirmer‐Mikalsen, A Vik, SE Gisvold, T Skandsen, H Hynne, ... Acta Anaesthesiologica Scandinavica 51 (9), 1194-1201, 2007 | 145 | 2007 |
| Immediate-or sustained-release morphine for dose finding during start of morphine to cancer patients: a randomized, double-blind trial P Klepstad, S Kaasa, Å Jystad, B Hval, PC Borchgrevink Pain 101 (1), 193-198, 2003 | 140 | 2003 |
| Polypharmacy in patients with advanced cancer and pain: a European cross-sectional study of 2282 patients A Kotlinska-Lemieszek, Ø Paulsen, S Kaasa, P Klepstad Journal of pain and symptom management 48 (6), 1145-1159, 2014 | 127 | 2014 |
| for the European Palliative Care Research Collaborative (EPCRC) on behalf of the European Association for Palliative Care (EAPC). Use of opioid analgesics in the treatment of … A Caraceni, G Hanks, S Kaasa, MI Bennett, C Brunelli, N Cherny, O Dale, ... Lancet Oncol 13 (2), e58-e68, 2012 | 127 | 2012 |
